000			01484 a2200445 4500
005			20250513143744.0
264		0	_c19980622
008			199806s 0 0 eng d
022			_a0969-7128
024	7		_a10.1038/sj.gt.3300621 _2doi
040			_aNLM _beng _cNLM
100	1		_aMcKie, E A
245	0	0	_aSelective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector--potential glioblastoma targeting. _h[electronic resource]
260			_bGene therapy _cApr 1998
300			_a440-50 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAstrocytes
650	0	4	_aBrain Neoplasms _xtherapy
650	0	4	_aGene Expression
650	0	4	_aGenetic Therapy _xmethods
650	0	4	_aGenetic Vectors _xadministration & dosage
650	0	4	_aGlial Fibrillary Acidic Protein _xgenetics
650	0	4	_aGlioblastoma _xtherapy
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aMice
650	0	4	_aPromoter Regions, Genetic
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aSimplexvirus
650	0	4	_aStaining and Labeling
650	0	4	_aTransgenes
650	0	4	_aTumor Cells, Cultured
650	0	4	_abeta-Galactosidase _xgenetics
700	1		_aGraham, D I
700	1		_aBrown, S M
773	0		_tGene therapy _gvol. 5 _gno. 4 _gp. 440-50
856	4	0	_uhttps://doi.org/10.1038/sj.gt.3300621 _zAvailable from publisher's website
999			_c9581122 _d9581122